Target intelligence / Profile preview

Glucose transporter protein (GLUT) family (GLUT)

Target
GLUT
Molecular classification
Transporter, Major facilitator superfamily (MFS), Membrane protein
01

Overview

The GLUT family consists of integral membrane proteins that facilitate the transport of glucose and other hexoses such as fructose and galactose into and out of cells, driven by concentration gradients (facilitated diffusion). Structurally, most GLUT proteins possess 12 transmembrane domains and are part of the major facilitator superfamily, encoded by SLC2 genes. There are at least 14 identified human GLUT isoforms (GLUT1–GLUT14), each with tissue-specific expression and substrate selectivity: GLUT1 is ubiquitous and upregulated in many tumors, GLUT2 is abundant in liver and pancreas, GLUT3 is dominant in neurons, and GLUT4 is insulin-responsive in muscle and adipose tissue. Alterations in GLUT expression or activity are directly implicated in metabolic diseases (like diabetes), cardiovascular disease, and cancer, making these proteins important diagnostic biomarkers and potential therapeutic targets. The development of isoform-selective inhibitors and modulators is ongoing for disease treatment and research purposes. If more granular, isoform-specific data (e.g., for GLUT1, GLUT4) are required for structured usage, returning those as discrete entries is advisable.

Other names
Facilitative glucose transporterSLC2 family
02

Mechanism of action

Competitive inhibition of glucose binding (inhibitors); Modulation of transporter conformation

03

Biological functions

Glucose uptakeHexose transport (e.g., glucose, fructose, galactose)Energy homeostasisCell metabolic regulation
04

Disease associations

Diabetes mellitus (type 2, insulin resistance)CancerGenetic metabolic disordersTissue-specific syndromes
05

Safety considerations

Hypoglycemia risk (if glucose transport is excessively inhibited)Impaired tissue glucose uptake and energy metabolismPossible off-target effects due to widespread expression of individual GLUT isoforms
06

Interacting drugs

Cytochalasin B (inhibitor, experimental)

1 more in the full profile.

07

Biomarkers

GLUT1 expression for cancer diagnosis/prognosisGLUT4 translocation/activity for insulin sensitivity/diabetes

Beyond the preview

Go deeper on Glucose transporter protein (GLUT) family (GLUT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucose transporter protein (GLUT) family (GLUT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call